Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zezhong Liu

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Cell|January 31, 2025
Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral targetLixiao Xing, Zhimin Liu, Xinling Wang, et al.
Immunity|September 23, 2021
Inhibition of viral suppressor of RNAi proteins by designer peptides protects from enteroviral infection in vivoYuan Fang, Zezhong Liu, Yang Qiu, et al.
Cell Research|January 20, 2022
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPsZezhong Liu, Jie Zhou, Wei Xu, et al.
Nature|March 27, 2025
STING agonist-based ER-targeting molecules boost antigen cross-presentationXiafeng Wang, Zhangping Huang, Lixiao Xing, et al.
Cell Reports|January 24, 2021
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBDYunjiao Zhou, Zezhong Liu, Shibo Li, et al.
Protein & Cell|September 23, 2021
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitopeZezhong Liu, Wei Xu, Zhenguo Chen, et al.
Nature Nanotechnology|June 17, 2026
Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protectionZezhong Liu, Jie Zhou, Ruiyu Gao, et al.
Nature Biomedical Engineering|July 8, 2025
Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infectionsCuifeng Li, Yuxin Li, Bini Zhou, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cell|January 31, 2025
Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral targetLixiao Xing, Zhimin Liu, Xinling Wang, et al.
Immunity|September 23, 2021
Inhibition of viral suppressor of RNAi proteins by designer peptides protects from enteroviral infection in vivoYuan Fang, Zezhong Liu, Yang Qiu, et al.
Cell Research|January 20, 2022
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPsZezhong Liu, Jie Zhou, Wei Xu, et al.
Nature|March 27, 2025
STING agonist-based ER-targeting molecules boost antigen cross-presentationXiafeng Wang, Zhangping Huang, Lixiao Xing, et al.
Cell Reports|January 24, 2021
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBDYunjiao Zhou, Zezhong Liu, Shibo Li, et al.
Protein & Cell|September 23, 2021
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitopeZezhong Liu, Wei Xu, Zhenguo Chen, et al.
Nature Nanotechnology|June 17, 2026
Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protectionZezhong Liu, Jie Zhou, Ruiyu Gao, et al.
Nature Biomedical Engineering|July 8, 2025
Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infectionsCuifeng Li, Yuxin Li, Bini Zhou, et al.
Pageof 5